Milligan Sandra — SEC insider filings

SEC reporting owner CIK 1859810. 27 insider filings on record with FilingPulse; latest filed 2026-09-25.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2021-06-04 to 2026-09-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Gossamer Bio, Inc. (GOSS)Director92 legs · 58,050 sh · $75,229—7
Organon & Co. (OGN)Head of Research & Development10——41
Aspira Women's Health Inc. (AWH)Interim CEO5——8
Spyre Therapeutics, Inc. (SYRE)Director3——3

Insider filings — Milligan Sandra

FiledFormIssuerReported transactionsSource
2026-09-254Gossamer Bio, Inc. (GOSS)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2026-06-054Gossamer Bio, Inc. (GOSS)Grant/award (A): 115,000 (derivative) @ $0EDGAR
2026-05-294Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 8,026 (derivative) @ $0EDGAR
2025-08-204Gossamer Bio, Inc. (GOSS)Purchase (P): 26,050 @ $1.92EDGAR
2025-06-264Gossamer Bio, Inc. (GOSS)Grant/award (A): 115,000 (derivative) @ $0EDGAR
2025-06-024Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-01-294/AAspira Women's Health Inc. (AWH)Option exercise (M): 20,000 @ $0 · Tax withholding (F): 6,356 @ $0.70 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2025-01-084Aspira Women's Health Inc. (AWH)Option exercise (M): 20,000 @ $0 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-11-134Aspira Women's Health Inc. (AWH)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-10-284Aspira Women's Health Inc. (AWH)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2024-06-064Gossamer Bio, Inc. (GOSS)Grant/award (A): 115,000 (derivative) @ $0EDGAR
2024-05-164Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 21,980 (derivative) @ $0EDGAR
2024-05-064Aspira Women's Health Inc. (AWH)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-11-174Gossamer Bio, Inc. (GOSS)Purchase (P): 32,000 @ $0.79EDGAR
2023-06-094Gossamer Bio, Inc. (GOSS)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2023-05-084Organon & Co. (OGN)Option exercise (M): 4,984 · Tax withholding (F): 2,168 @ $24.24 · Option exercise (M): 4,984 (derivative) @ $0EDGAR
2023-05-034Organon & Co. (OGN)Option exercise (M): 1,899 · Tax withholding (F): 826 @ $24.63 · Option exercise (M): 1,899 (derivative) @ $0EDGAR
2023-04-044Organon & Co. (OGN)Option exercise (M): 5,964 @ $0 · Tax withholding (F): 2,115 @ $23.09 · Option exercise (M): 5,964 (derivative) @ $0 · Grant/award (A): 29,230 (derivative) @ $0 · Grant/award (A): 104,961 (derivative) @ $0EDGAR
2023-03-024Organon & Co. (OGN)Option exercise (M): 7,976 · Tax withholding (F): 2,346 @ $25.09 · Option exercise (M): 7,976 (derivative) @ $0EDGAR
2022-07-154Gossamer Bio, Inc. (GOSS)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-05-054Organon & Co. (OGN)Option exercise (M): 1,842 · Tax withholding (F): 525 @ $32.08 · Option exercise (M): 4,984 · Tax withholding (F): 1,806 @ $32.44 · Option exercise (M): 1,842 (derivative) @ $0 · Option exercise (M): 4,984 (derivative) @ $0EDGAR
2022-05-034Organon & Co. (OGN)Option exercise (M): 1,896 · Tax withholding (F): 540 @ $32.33 · Option exercise (M): 1,896 (derivative) @ $0EDGAR
2022-04-044Organon & Co. (OGN)Grant/award (A): 17,892 (derivative) @ $0 · Grant/award (A): 55,114 (derivative) @ $0EDGAR
2022-03-024Organon & Co. (OGN)Option exercise (M): 10,171 · Tax withholding (F): 2,941 @ $37.57 · Option exercise (M): 10,171 (derivative) @ $0EDGAR
2021-08-194Organon & Co. (OGN)Grant/award (A): 22,321 (derivative) @ $0EDGAR
2021-06-144Gossamer Bio, Inc. (GOSS)Grant/award (A): 47,000 (derivative) @ $0EDGAR
2021-06-044Organon & Co. (OGN)Grant/award (A): 1,842 (derivative) @ $0 · Grant/award (A): 3,795 (derivative) @ $0 · Grant/award (A): 14,957 (derivative) @ $0 · Grant/award (A): 10,170 (derivative) @ $0 · Grant/award (A): 7,975 (derivative) @ $0 · Grant/award (A): 19,828 (derivative) @ $0 · +6 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2021-06-03 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1859810 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs